Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD19 antibody

This anti-CD19 antibody is a Mouse Monoclonal antibody detecting CD19 in IHC and ELISA. Suitable for Human. This Primary Antibody has been cited in 1 publication.
Catalog No. ABIN969471

Quick Overview for CD19 antibody (ABIN969471)

Target

See all CD19 Antibodies
CD19 (CD19 Molecule (CD19))

Reactivity

  • 325
  • 157
  • 46
  • 32
  • 19
  • 13
  • 6
  • 5
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Human

Host

  • 212
  • 132
  • 52
  • 6
  • 4
  • 4
  • 2
Mouse

Clonality

  • 283
  • 118
  • 6
Monoclonal

Conjugate

  • 132
  • 25
  • 24
  • 22
  • 18
  • 8
  • 8
  • 8
  • 7
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
This CD19 antibody is un-conjugated

Application

  • 305
  • 119
  • 78
  • 69
  • 67
  • 63
  • 29
  • 21
  • 20
  • 14
  • 14
  • 11
  • 9
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), ELISA

Clone

2E2B6B10
  • Purpose

    CD19 Antibody

    Purification

    Ascitic fluid

    Immunogen

    Purified recombinant fragment of human CD19 expressed in E. Coli.

    Isotype

    IgG2b
  • Application Notes

    ELISA: 1/10000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Ascitic fluid containing 0.03 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • de Rie, Zeijlemaker, von dem Borne: "Inhibition, by vinca alkaloids and colchicine, of antigenic modulation induced by anti-CD19 monoclonal antibodies." in: Leukemia research, Vol. 12, Issue 2, pp. 135-41, (1988) (PubMed).

  • Target

    CD19 (CD19 Molecule (CD19))

    Alternative Name

    CD19

    Background

    The CD19 antigen (95 kDa) is expressed from the earliest stage of B progenitor development, on all
    peripheral B cells including germinal centre B cells, and all B cell lines and B cell leukaemia
    tested. T cell and monocytic cell lines are negative and the antigen is lost on B cell maturation
    to plasma cells. The antigen is a type I integral membrane glycoprotein whose in vitro inhibition
    will influence B cell activation and proliferation.

    UniProt

    P15391

    Pathways

    Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
You are here:
Chat with us!